RECRUITING

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Description

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Conditions

Nicotine UseTobacco Use
Talk to us

Related Conditions:

Nicotine UseTobacco Use

Study Overview

On this page

Study Details

Study overview

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Condition
Nicotine Use
Intervention / Treatment

-

Contacts and Locations

Gainesville

University of Florida, Gainesville, Florida, United States, 32608

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
  • * Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment.
  • * Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology).
  • * Capable of completing study requirements
  • * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
  • * Adults aged ≥18 years
  • * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
  • * A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above
  • * Capable of completing study requirements
  • * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
  • * Adults aged ≥18 years
  • * Patients unable to complete the sessions because of language, travel or technology barriers
  • * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.
  • * Participants unable to complete the sessions because of language, travel or technology barriers
  • * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Florida,

Jennifer LeLaurin, PhD, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

2026-11